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1. Introduction 
Gastritis, inflammation of gastric mucosa, is a very common condition in the world wide. 
There is no universally accepted classification of gastritis. Early classification was based 
mainly on the morphology, but recently pathogenic mechanisms have also been 
incorporated. The Sydney system, a classification of gastritis introduced in 1990, and 
updated in 1995, has included both an endoscopic and histologic divisions and is designed 
for an unambiguous uniform reporting system. (Dixon, Genta et al. 1996) 
The histologic changes of acute gastritis include hyperemia, edema, and infiltration of 
polymorphonuclear cells, together with variable loss of epithelium. Endoscopically, these 
changes can be observed as edema, petechial or submucosal hemorrhage, erosions or ulcers. 
A lot of factors including nonsteroidal anti-inflammatory drugs (NSAIDs) and various 
noxious substances may result in these acute abnormalities. Excess production of reactive 
oxygen species evokes oxidative stress, which can induce apoptosis and autophagy in the 
damaged tissue or cells. Oxidative stress induced by the NSAIDs and various noxious 
substances may contribute to the pathophysiologic and histopathologic alterations including 
autophagy and apoptosis, leading to gastritis.  
The discovery of Helicobacter pylori has markedly improved our understanding about the 
nature of chronic gastritis and other important gastroduodenal diseases. (Marshall 1983; 
Warren 1983) H. pylori have been accepted as the most common cause of chronic gastritis. 
(Suerbaum and Michetti 2002) Colonization of gastric mucosa by H. pylori is always 
associated with persistent inflammation. Several virulence factor derived from H. pylori may 
promote these inflammatory mucosal changes. H. pylori-associated chronic gastritis usually 
accompanies with polymorphonuclear infiltration and architectural change of the gastric 
mucosa. There are marked mucosal cellular and systemic humoral immunologic responses. 
The mucosal damage seen in patients with H. pylori may result from both the effect of 
immunologic response and the bacterial toxin. Apoptosis and autophagy may contribute to 
cell homeostasis in gastric epithelial cells subjected to H. pylori infection. The combination of 
antioxidant and anti-adhesion materials can be attenuated the severity of gastritis.  
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2. Epidemiology 
More than 50% of population in the world is infected with this bacterium. The prevalence of 
infection is increased with age and thought to be a cohort effect. 
Epidemiologic studies show this infection is generally acquired during childhood and the 
majority of H. pylori transmission is through close person-to-person contact. The oral-oral, 
gastro-oral, or fecal-oral exposure seems the most probable explanation for infection. 
(Brown 2000; Amieva, El-Omar et al. 2008)  
3. Pathogenesis 
Bacterial factor and colonization 
H. pylori infection is closely associated with chronic active type B gastritis, peptic ulcers, 
gastric cancer and gastric MALT lymphoma. The pre-neoplastic lesions, such as glandular 
atrophy and intestinal metaplasia, may consequently result from persistent chronic gastritis 
in some patients. The outcome of H. pylori infection depends on the combination of bacterial 
and host factors in addition to less well-defined environmental conditions. 
H. pylori are one of few organisms capable of colonizing the harsh environment of the 
human stomach. The initial step in H. pylori infection is the penetration and adherence of the 
bacterium to mucin and epithelial cells. H. pylori generate large amounts of cytosolic and cell 
surface-associated urease. The urease helps the organism to avoid the bactericidal activity of 
gastric acid. H. pylori can use its polar flagella to migrate rapidly to a more favorable 
environment below the mucus layer very close to the surface of the epithelium where the 
pH is near neutral. 
After H. pylori migrate to the gastric epithelium, the bacteria adhere to the surface of host 
cells and may damage them in order to obtain nutrients and establish persistent 
colonization. Several different adhesion molecules have been identified and classified as 
adhesins. (Boren, Falk et al. 1993) The best studied H. pylori adhesins are outer membrane 
proteins that bind carbohydrate modifications in the glycoproteins of epithelial cells. The 
specific bacterial gene product, BabA, act as the ligand for the fucosylated blood group 
antigen Lewis b receptor. (Ilver, Arnqvist et al. 1998) The SabA protein adheres to sialated 
glycoproteins, specifically to sialyl-Lewis-X. (Mahdavi, Sonden et al. 2002) 
A segment of bacterial DNA, known as the cag pathogenicity iland (cag PAI), direct the key 
interaction between H. pylori and the host cells. Many of the genes adjacent to cagA encode 
proteins that provide a type IV secretion system (TFSS) that allows the transfer of bacterial 
products from pathogenic bacteria into the host cell. (Censini, Lange et al. 1996; Christie, 
Atmakuri et al. 2005)  cag PAI plays an important role in the pathogenesis of gastritis. 
Patients infected with cagA positive strain of H. pylori are generally associated with increase 
interleukin-8 (IL-8) expression and inflammation in their gastric mucosa. (Blaser and 
Atherton 2004) CagA protein translocates into the cytoplasm of epithelial cell where it is 
tyrosine phosphorylated by host Src kinases and subsequently results in the change of cell 
morphology and cell function. (Higashi, Tsutsumi et al. 2002; Higashi, Tsutsumi et al. 2002) 
The response of epithelial cell to H. pylori infection is complex and a summary of interaction 
with several influencing variables, such as bacterial virulence factors, the signaling linked to 
specific receptors, reaction of immune and hormones. 
The vacA gene is present in all strains of this organism. However, only more than half of H. 
pylori strains are able to express the vacuolating cytotoxin (VacA). The association of the 
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structure and function of VacA with the severity of disease has been demonstrated. (Cover 
1996; Van Doorn, Figueiredo et al. 1999; Blaser and Atherton 2004). Specific vacA alleles (s1 
and m1) can result in more severe disease and epithelial cell apoptosis. (Atherton, Cao et al. 
1995; Cover, Krishna et al. 2003) 
H. pylori strains that express outer inflammatory protein A (OipA) are also associated with 
increased expression of IL-8, neutrophil infiltration, and more severe clinical outcomes. 
(Yamaoka, Kikuchi et al. 2002) 
Host response 
The host response to H. pylori infection plays a very important role in the pathogenesis of 
this organism related gastrointestinal disease. The IL-1 is known as a strong inhibitor of 
gastric acid secretion. The genetic polymophisms of IL-1┚ have been demonstrated to be 
associated with an increased incidence of hypochlorhydria, atrophic gastritis and gastric 
cancer. (El-Omar, Carrington et al. 2000; Furuta, El-Omar et al. 2002) The development of 
gastric cancer can be related to increase IL-1 expression, more severe gastritis and greater 
colonization of H. pylori. 
H. pylori infection can result in changes in epithelial cell morphology, disruption of the tight 
junction, production of cytokines, increased epithelial cell proliferation, and increased rates 
of epithelial cell death via apoptosis. (Amieva, Vogelmann et al. 2003; Naumann and 
Crabtree 2004; Ernst, Peura et al. 2006) 
The induction and expression of genes in epithelial cells responding to H. pylori stimulation 
is regulated by several transcription factors which are controlled by a series of signaling 
mechanisms. The nuclear factor-kappa B (NF-kB) seems to be the most studied molecule in 
these transcription factors. NF-kB activity in H. pylori infected epithelium is markedly 
enhanced, correlating with increased secretion of IL-8 protein and infiltration of 
inflammatory cell. (Naumann and Crabtree 2004) The changes of cell functions, including 
cell profiferation, inflammation, and survival in response to H. pylori infection are mostly 
regulated by mitogen-activated protein (MAP) kinase cascades. (Keates, Keates et al. 1999) 
The acid secretion is a major function of gastric epithelial cells. The net effect of H. pylori 
infection on acid secretion is related to the duration and distribution of infection and the 
presence of mucosal atrophy. The epithelial barrier function is altered as a consequence of 
both direct effects of H. pylori and its accompanying inflammatory response. Humans 
infected by H. pylori develop a unique inflammatory response in which infection persists 
despite the recruitment and activation of lymphocytes, phagocytic cells, and other immune 
cell populations. (Ernst, Peura et al. 2006) 
It is known that H. pylori can induce an infiltration with T lymphocytes, plasma cells, 
mononuclear phagocytes and neutrophils. Furthermore, expression of cytokines such as 
tumor necrosis factor (TNF), IL-1, IL-6 and IL-8 is also enhanced by the infection. However, 
it is not well known how the immune response and the mechanisms behind it related to 
disease outcome. The immunoregulatory and proinflammatory cytokines induced by H. 
pylori may influence the nature of the local T cell response. It is thought that helper T (Th) 
cells can be divided into two subsets, Th1, and Th2. The Th1 subset promotes cell-mediated 
immunity by producing mainly IL-2, TNF-┙, and interferon-gamma (IFN-γ), and the Th2 
subset, which is important for antibody response produces IL-4, IL-5 and IL-10. Evidences in 
recent research have strongly suggested that T cell mediated immune response may play an 
important role in induction of disease in H. pylori infection. (Crowe, Alvarez et al. 1995; 
D'Elios, Manghetti et al. 1997; Mohammadi, Nedrud et al. 1997) It is still not clear whether 
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different outcome of the disease is modulated by the different type of T cell immune 
response, although some studies suggested that Th1 type dominant cellular response may 
be involved in the Helicobacter disease. (Haeberle, Kubin et al. 1997) Little is known about 
whether Th2 response can be protective or whether modulation of these responses can 
change the outcome of infection. 
Apoptosis and autophagy 
Some bacterial components may reach the lamina propria where it can activate underlying 
phagocytosis through the damaged epithelial barrier. One of these bacterial factors is the H. 
pylori neutrophil-activating protein (Hp-NAP). This protein can promote the adhesion of 
neutrophil to the endothelial cells and stimulate chemotaxis of monocytes and neutrophils 
and production of reactive oxygen intermediates. (Satin, Del Giudice et al. 2000) 
Recruitment and activation of neutrophils and macrophages result in the release of various 
inflammatory mediators. 
H. pylori urease has been shown to bind to class II major histocompatibility complex (MHC) 
molecules on the surfaces of gastric epithelial cells and induce apoptosis. (Fan, Gunasena et 
al. 2000) H. pylori VacA can be inserted into mitochondrial membranes where it induces 
cytochrome c release and activates the caspase-3-dependent cell-death signaling cascade. 
(Galmiche, Rassow et al. 2000) Also, Th1 cytokines induced by H. pylori can stimulate 
apoptosis through a Fas-mediate pathway by inducing expression of the cell-surface 
receptor Fas and Fas ligand. (Wagner, Beil et al. 1997; Jones, Day et al. 1999; Smythies, 
Waites et al. 2000) 
The expression of inducible nitric oxide synthase (iNOS) is increased in H. pylori infected 
gastric mucosa. Nitric oxide (NO) and Superoxide (O2-) may be produced by infiltrating 
neutrophils. These reactive oxygen species (ROS) can react to form peroxynitrite which is a 
potent oxidant and reducing agent. Apurinic–apyrimidinic endonuclease-1 (redox factor-1) 
plays an important role in the regulation of redox-sensitive signaling and is expressed in 
epithelial cell during infection with H. pylori. (Ding, O'Hara et al. 2004; O'Hara, 
Bhattacharyya et al. 2006) The increased oxidative DNA damage by ROS is thought to play a 
causal role in malignant transformation. The cells which undergo apoptosis are removed by 
phagocytes. This engulfment of H. pylori infected epithelial cells by phagocytes plays an 
important role in the cytokine induction and the activation of host adaptive response. 
An increase of chronic inflammatory cells in the gastric mucosa indicates the presence of a 
chronic gastritis that may result from the increased oxidative stress. Apoptosis and 
autophagy are two types of programmed cell death that play a critical role in tissue 
homeostasis and disease development. Exacerbated production of ROS in the inflamed 
tissue results in substantial type I programmed cell death, apoptosis, including increases in 
Bax/Bcl-2 ratio, caspase-3 activity, DNA fragmentation and apoptotic cell formation in the 
damaged tissue. (Baik, Youn et al. 1996; Smoot, Elliott et al. 2000; Chien, Lee et al. 2001; Yu, 
Chien et al. 2004; Yu, Lin et al. 2005)  
Autophagy is type II programmed cell death and is a major lysosomal catabolic pathway for 
cytoplasmic macromolecules and organelles. Autophagy could be mediated by Beclin-1, a 
novel Bcl-2-interacting protein, to promote autophagocytosis and a cell-survival response. 
(Blommaart, Luiken et al. 1997; Liang, Jackson et al. 1999) Previous studies have indicated 
that H. pylori-induced gastric epithelial cell damage by increased Bax/Bcl-2-related 
proapoptotic cell death and decreased autophagy survival and/or repair. (Catrenich and 
Chestnut 1992; Lee, Yeo et al. 2004) 
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4. Clinical and therapeutic application 
How to prevent and cure H. pylori infection associated with gastritis is an important issue. 
Nowadays the first-choice of therapy for H. pylori infection is one-week combination of a 
proton pump inhibitor and antibiotics. Following failure of the first-line treatment, second-
line therapies, including alternative triple and quadruple regimens, have frequently been 
applied to the patients. (Chey, Wong et al. 2007; Malfertheiner, Megraud et al. 2007) 
Although, the current antibiotic-based therapies are generally effective, it may still fail 
because of the rising trend of antibiotic resistance or the low compliance. (Megraud 2004; 
Vakil, Megraud et al. 2007) To find out an alternative agent or mixture with preventive and 
therapeutic potential on H. pylori infection is therefore urgently required. 
Some strains of Lactobacillus and Bifidobacterium can inhibit H. pylori growth. However, 
probiotics do not eradicate H. pylori but maintain a lower level of this pathogen in the 
stomach.(Gotteland, Brunser et al. 2006) A vaccine can be used either propbylactically or 
therapeutically for H. pylori infection. In the mice, vaccination can result in significantly 
reduced H. pylori colonization but it cannot achieve satisfactory eradication or prevention of 
H. pylori infection. (Del Giudice, Covacci et al. 2001) 
A successful H. pylori infection requires the penetration and adherence of the bacterium to 
mucin and gastric epithelial cells. H. pylori that adheres to gastric mucosa subsequently 
causes gastric epithelial cell damage and atrophy via oxidative stress and the type I 
apoptotic or type II autophagic programmed cell death-related pathway. Sialylated 
glycoconjugates are responsible for the adherence of H. pylori to gastric epithelium. 
Cumulated studies have shown that anti-adhesive therapy using 3’-sialyllactose can prevent 
the binding of H. pylori to human gastrointestinal epithelial cells and decrease H. pylori 
colonization in rhesus monkeys without side-effects. (Simon, Goode et al. 1997; Mysore, 
Wigginton et al. 1999) 
Catechins, known as one kind of antioxidants, have been shown to possess anti-oxidative, 
anti-inflammatory, anti-apoptotic and cancer prevention activity. (Katiyar and Mukhtar 
1996; Lin and Lin 1997; Yu, Lin et al. 2005) Besides, catechins including their major active 
component, epigallocatechin-3-gallate (EGCG), have antibacterial effect against H. pylori by 
inhibiting the activity of urease and VacA of this organism. (Mabe, Yamada et al. 1999; 
Matsubara, Shibata et al. 2003; Ruggiero, Tombola et al. 2006) 
Although catechins or 3’-sialyllactose have an inhibitory effect on H. pylori infection in vitro, 
these two compounds fail to effectively control infection in animal model in vivo when each 
is used alone. (Mabe, Yamada et al. 1999; Mysore, Wigginton et al. 1999; Matsubara, Shibata 
et al. 2003) However, effective prevention and treatment of H. pylori infection using a 
combination of catechins and sialic acid in AGS cells and BALB/c mice have been shown in 
a recent study. (Yang, Shun et al. 2008) The combination of catechins and sialic acid showed 
synergistic or additive anti-H. pylori activity and significantly reduced iNOS expression and 
Bax/BCl-2-mediated apoptosis but enhanced Becline-1 mediated autophage. Pretreatment 
with catechins/sialic acid completely prevented H. pylori infection and resulted in normal 
histology. Post-treatment with catechins/sialic acid decreased the bacterial load and 
gastritis score and eradicated up to 60% of H. pylori infectious in a dose-dependent manner. 
 The rationale of this treatment model which can effectively control H. pylori infection 
includes several points. (Yang and Chien 2009) First, by reviewing the literature, we can find 
that monotherapy using a single drug such as PPI, bismuth salt, or antibiotics always fail to 
eradicate H. pylori in humans, although each of these drugs can work in vitro. (Bamba, 
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Kondo et al. 1997) Thus, dual therapy, then triple therapy, and even quadruple therapy have 
been recommended step by step. Second, catechins have antioxidant and anti-microbial 
effects (Lin and Lin 1997; Mabe, Yamada et al. 1999), whereas sialic acid has anti-adhesive 
and antioxidant effects. (Simon, Goode et al. 1997; Teneberg, Jurstrand et al. 2000) Together, 
they may have additive or synergistic effect against H. pylori. Third, both catechins and sialic 
acid can exist in the foodstuff are wildly accepted to be very safe to humans. 
5. Conclusions 
It is now clear that both bacterial factors and host response play a role in the pathogenesis of 
H. pylori related gastroduodenal disease. H. pylori infection can cause gastric mucosal injury, 
including oxidative stress, inflammation, and apoptosis formation but inhibit the autophagic 
survival response in gastric epithelial cell as indicated in Figure 1. A new strategy for 
control of H. pylori infection is to interfere with the interaction between the bacteria and 
target cells and to eradicate bacteria but not target cells at the same time. The combination of 
compounds with anti-adhesive, antioxidant, and anti-microbial activities may protect gastric 
mucosa from infection by H. pylori and treat its related gastritis via downregulation of 
apoptosis and upregulation of autophagy. 
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Fig. 1. Possible pathways of H. pylori invade gastric epithelium via a upregulation in 
oxidative stress, inflammation and apoptosis and a downregulation in autophagy. The 
combination of antioxidants and anti-adhesion drug may reduce H. pylori-induced gastritis. 
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